What Trump's generic drug tariffs could mean, according to experts
Summary
President Trump announced tariffs of up to 200% on imported generic drugs starting in 2028 to encourage companies to move production back to the U.S. Experts say the tariffs alone may not be enough to convince manufacturers to reshore due to high costs and complex production needs. The tariffs could lead to modest price increases for consumers because generic drugs usually cost less than brand-name drugs.Key Facts
- Tariffs on imported generic drugs will start at 100% in August 2028 and rise to 200% after one year.
- The goal is to bring generic drug manufacturing back to the U.S. (reshoring).
- Generic drugs make up about 90% of prescriptions filled in the U.S.
- Over half of generic drugs are currently supplied from India, with significant imports from China for drugs like ibuprofen and acetaminophen.
- Experts say moving production to the U.S. is expensive and may not happen quickly due to required specialized facilities.
- Higher tariffs might increase drug prices slightly but generic drug prices are generally low to begin with.
- The administration offers other policies to support reshoring, like full equipment expensing.
- Major generic drug companies have not confirmed plans to expand U.S. manufacturing yet.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
